Defibrillators devices are used to deliver therapeutic shock to a patients heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations has fueled the market growth. Moreover, advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases among all ages are further driving the market growth. However, product failures and recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.

In addition, external defibrillators are categorized into manual external defibrillator (MEDs), automated external defibrillator (AEDs) & wearable cardioverter defibrillator (WCDs). AEDs are most commonly used external defibrillator accounting for more than two-thirds of external defibrillator market revenue in 2015. However, WCDs are gaining express momentum and is expected to churn substantial revenue share of both MEDs and AEDs during forecast period due its easy to use and wearable features.

 AED is the preferred external defibrillation system:

SCA is the leading cause of death globally, which is a life-threatening condition. It can be treated successfully by early intervention of the disease with defibrillation at the right time. The global external defibrillators market is dominated by automated external defibrillators (AEDs) and expected to grow with highest rate in future due to increase in adoption by heart failure patients across the globe. The increasing installations of public access AEDs, growing incidence of cardiovascular diseases, and growing awareness regarding the lifesaving potential of AEDs have fueled the market growth. The second largest market of external defibrillators is covered by manual external defibrillators followed by wearable external defibrillators.

Developing occurrence of sudden heart failure (SCA) and cardiovascular illnesses: throttling the market development 

American Heart Association, 5.5 million individuals are influenced by heart disappointment in the U.S. alone, while 10 million in European nations. Moreover, in the U.S., around 700,000 new instances of heart disappointment are analyzed every year and roughly 58,000 patient passings are credited to heart disappointment every year. This is one of the real driving variables for the development of the defibrillators showcase. Additionally, the rising rate of diabetes, atherosclerosis, strokes, hypertension, and others because of way of life propensities, for example, unfortunate dietary propensities, absence of physical movement and smoking, among others, is the main source of CHF. Additionally, rising geriatric populace base is relied upon to fuel the pervasiveness of CHFs, in this way expanding the market development. 
 

Inquire About Report: https://www.progressivemarkets.com/enquiry-about-report/defibrillator-market

DEFIBRILLATORS MARKET SEGMENTS By Product

• Implantable Defibrillators
  • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
  • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
  • Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
• External defibrillators
  • Manual External Defibrillator
  • Automated External Defibrillator (AEDs),
  • Wearable Cardioverter Defibrillator (WCDs).
     

Company Profiles Included

• Asahi Kasei Corporation
• Stryker Corporation
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Philips Healthcare (A Division of Koninklijke Philips N.V.)
• LivaNova PLC
• Medtronic PLC
• St. Jude Medical, Inc.
• Cardiac Science Corporation
• Nihon Koden Corporation

Inquire For Sample: https://www.progressivemarkets.com/request-sample/defibrillator-market

About Us
The company found with an initiative to bridge the gap between enterprises and global opportunities. It is driven by the sole motive to build an effective channel to communicate up-to-date qualitative and quantitative market intelligence with all-scale participants. The company makes use of primary corporate research and secondary inputs from trusted sources to build its own reference base

Reach Us
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int'l:       +1-971-202-1575
Toll Free:   ++ 1-800-910-6452
Fax:   +1-800-792-5285
help@progressivemarkets.com